David S. Nagelberg Reports 8.6% Beneficial Ownership in PAVmed Inc. (PAVM)

On April 8, 2026, David S. Nagelberg and the David S. Nagelberg 2003 Revocable Trust filed a Schedule 13G with the SEC, reporting a combined beneficial ownership of 546,964 shares of PAVmed Inc. (PAVM) common stock. This position represents an 8.6% ownership stake in the company, based on 6,383,089 shares outstanding as of March 27, 2026. Specifically, the Trust holds 461,539 shares (7.2%), while Mr. Nagelberg personally owns an additional 85,425 shares. Because Mr. Nagelberg controls the Trust, he is deemed to have sole voting and dispositive power over the aggregate 546,964 shares. The filing indicates that these shares were acquired for investment purposes and not with the intent to change or influence the control of the issuer. This filing marks a significant new reported position for the reporting persons, as the previous ownership percentage was 0.0%. The principal business office for the reporting persons is located in New York, NY.